Insiders ORIC Pharmaceuticals, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 15:15:19 08/05/2024 BST			5-day change	1st Jan Change
9.45 ^USD	-1.66%		+1.13%	+2.55%

05-06	ORIC Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-15	ORIC Pharmaceuticals Doses First Patients in Expansion Groups in Phase 1b Trial of ORIC-114 to Treat Lung Cancer	MT

Oric Pharmaceuticals Insider Sold Shares Worth $648,380, According to a Recent SEC Filing	03-08	MT
Oric Pharmaceuticals Insider Sold Shares Worth $489,346, According to a Recent SEC Filing	02-09	MT
Investor Caution Ahead of GDP Data, Jobless Claims Subdues Exchange-Traded Funds, Equity Futures Premarket	22/12/22	MT
Insider Buy: Oric Pharmaceuticals	16/05/22	MT
Insider Buy: Oric Pharmaceuticals	28/03/22	MT
ORIC Pharmaceuticals, Inc. Announces Directorate Changes	10/11/21	CI
Insider Sell: Oric Pharmaceuticals	14/09/21	MT
Insider Sell: Oric Pharmaceuticals	09/09/21	MT
ORIC Pharmaceuticals, Inc. Announces Board Changes	16/08/21	CI
ORIC Pharmaceuticals Appoints Lori Kunkel to Its Board of Directors	09/06/20	CI
ORIC Pharmaceuticals, Inc. Appoints Christian V. Kuhlen as General Counsel	02/04/20	CI
ORIC Pharmaceuticals Appoints Mardi C. Dier to Its Board of Directors	02/03/20	CI
ORIC Pharmaceuticals Appoints Dominic Piscitelli as Chief Financial Officer	10/09/19	CI
ORIC Pharmaceuticals, Inc. Appoints Lori Friedman as Chief Scientific Officer	09/07/19	CI
ORIC Pharmaceuticals Names Edna Chow Maneval as Senior Vice President of Clinical Development	04/03/19	CI
ORIC Pharmaceuticals Appoints Matt Panuwat as Chief Business Officer	26/11/18	CI
ORIC Pharmaceuticals Appoints Pratik Multani as Chief Medical Officer	17/09/18	CI
ORIC Pharmaceuticals Announces Management Changes	07/05/18	CI
ORIC Pharmaceuticals, Inc. Announces Executive Changes	20/12/17	CI
ORIC Pharmaceuticals Announces Management Appointments	10/08/16	CI

No results for this search